{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:08:18Z","timestamp":1754399298579},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Familial hemophagocytic lymphohistiocytosis (FHL) is a fatal autosomal recessive immunodeficiency disease whose rapid and accurate diagnosis is paramount for appropriate treatment. Mutations in <jats:italic toggle=\"yes\">STXBP2<\/jats:italic> gene have been associated with FHL type 5 (FHL-5). Here, we report the first Tibetan Chinese patient diagnosed with FHL-5 caused by a novel compound heterozygous mutation in <jats:italic toggle=\"yes\">STXBP2<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 9-year-old girl who presented with recurrent fever, splenomegaly, pancytopenia, hypofibrinogenemia, and conspicuous bone marrow hemophagocytosis was diagnosed with haemophagocytic lymphohistiocytosis (HLH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>FHL mutation analysis of the patient and her parents revealed that she presented compound heterozygosity for <jats:italic toggle=\"yes\">STXBP2<\/jats:italic>: a novel missense mutation c.663G\u200a&gt;\u200aC (p.Glu221Asp) and the known pathogenic splice-site mutation c.1247-1G\u200a&gt;\u200aC (p.Val417LeufsX126). Bioinformatics analyses predicted that the new mutation was pathogenic and the FHL-5 diagnosis was confirmed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Upon diagnosis, HLH-2004-directed chemotherapy was instituted, but there was a relapse. Allogeneic hematopoietic stem cell transplantation (HSCT) was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After transplantation, the patient presented implantation dysfunction, chronic graft-versus-host disease, and 5 episodes of pancreatitis. A follow-up after 5 years revealed that the patient had died of pancreatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This finding expands the spectrum of FHL-5-related mutations in Chinese patients and indicates a clear genotype-phenotype correlation of FHL-5 in China.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017674","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:22:49Z","timestamp":1571858569000},"page":"e17674","source":"Crossref","is-referenced-by-count":4,"title":["Familial hemophagocytic lymphohistiocytosis type 5 in a Chinese Tibetan patient caused by a novel compound heterozygous mutation in STXBP2"],"prefix":"10.1097","volume":"98","author":[{"given":"Xue","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20240516","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2015.06.008","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"29","author":"Degar","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"R2-20240516","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2013-03-494039","article-title":"Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2\/Munc18-2 mutations","volume":"122","author":"Zhao","year":"2013","journal-title":"Blood"},{"key":"R3-20240516","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/pbc.25308","article-title":"Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden","volume":"62","author":"Meeths","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20240516","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20240516","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R6-20240516","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R7-20240516","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cge.12682","article-title":"Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2","volume":"89","author":"Seo","year":"2016","journal-title":"Clin Genet"},{"key":"R8-20240516","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","article-title":"Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)","volume":"119","author":"Pagel","year":"2012","journal-title":"Blood"},{"key":"R9-20240516","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","article-title":"Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion","volume":"125","author":"Spessott","year":"2015","journal-title":"Blood"},{"key":"R10-20240516","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pbc.24475","article-title":"Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2\/MUNC18-2 mutations","volume":"60","author":"Stepensky","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:08:42Z","timestamp":1715897322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017674","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}